We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+16.33%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.37B
AUM Growth
+$227M
Cap. Flow
-$5.81M
Cap. Flow %
-0.25%
Top 10 Hldgs %
19.78%
Holding
359
New
114
Increased
58
Reduced
128
Closed
21

Top Buys

Rank Stock Value
1
BRBR icon
BellRing Brands
BRBR
+$32M
2
QTS
QTS REALTY TRUST, INC.
QTS
+$18M
3
PRFT
Perficient Inc
PRFT
+$15.7M
4
AX icon
Axos Financial
AX
+$14.4M
5
ABCB icon
Ameris Bancorp
ABCB
+$13.4M

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$33M
2
CADE
Cadence Bancorporation
CADE
+$29.6M
3
VG
Vonage Holdings Corporation
VG
+$15.7M
4
ARQL
Arqule Inc
ARQL
+$15.6M
5
KPTI icon
Karyopharm Therapeutics
KPTI
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 21.26%
2 Consumer Discretionary 16.72%
3 Industrials 15.68%
4 Technology 14.21%
5 Consumer Staples 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
51
DELISTED
Radius Health, Inc.
RDUS
$18.1M 0.77%
899,867
-2,600
-0.3% -$63.1K
AJRD
52
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$17.6M 0.74%
385,188
+57,605
+18% +$2.61M
ZGNX
53
DELISTED
Zogenix, Inc.
ZGNX
$17.2M 0.73%
329,748
-3,210
-1% -$147K
LITE icon
54
Lumentum
LITE
$57B
$16.7M 0.71%
210,658
-820
-0.4% -$53.7K
LIVN icon
55
LivaNova
LIVN
$4.43B
$16.3M 0.69%
215,473
+30,404
+16% +$2.31M
INSM icon
56
Insmed
INSM
$23.5B
$16.1M 0.68%
674,167
-310,820
-32% -$6.32M
TDOC icon
57
Teladoc Health
TDOC
$1.7B
$16.1M 0.68%
192,085
-166,315
-46% -$12.7M
COLL icon
58
Collegium Pharmaceutical
COLL
$1.17B
$16.1M 0.68%
+780,820
New +$13M
CSFL
59
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$15.9M 0.67%
636,187
+15,560
+3% +$389K
ATSG
60
DELISTED
Air Transport Services Group
ATSG
$15.7M 0.66%
669,788
-243,693
-27% -$5.46M
DRNA
61
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$15.5M 0.65%
701,341
-172,268
-20% -$3.47M
GLUU
62
DELISTED
Glu Mobile Inc.
GLUU
$15.2M 0.64%
2,507,734
-15,110
-0.6% -$86.3K
QTWO icon
63
Q2 Holdings
QTWO
$3.43B
$15M 0.63%
185,272
-790
-0.4% -$60.7K
SAM icon
64
Boston Beer
SAM
$1.86B
$15M 0.63%
39,657
+26,801
+208% +$10.1M
PLCE icon
65
Children's Place
PLCE
$65.8M
$14.9M 0.63%
238,147
-36,050
-13% -$2.63M
AX icon
66
Axos Financial
AX
$5.66B
$14.9M 0.63%
+491,662
New +$14.4M
MC icon
67
Moelis & Co
MC
$5.02B
$14.8M 0.63%
464,941
-9,384
-2% -$307K
MTSI icon
68
MACOM Technology Solutions
MTSI
$20.4B
$14.6M 0.62%
+548,550
New +$13.1M
TMHC icon
69
Taylor Morrison
TMHC
$6.64B
$14.2M 0.6%
650,840
+434,360
+201% +$10.4M
PLMR icon
70
Palomar
PLMR
$3.59B
$14.1M 0.59%
278,405
+254,389
+1,059% +$11.9M
ATRC icon
71
AtriCure
ATRC
$1.77B
$13.9M 0.59%
428,519
-11,492
-3% -$327K
OLLI icon
72
Ollie's Bargain Outlet
OLLI
$4.02B
$13.5M 0.57%
206,698
-215,220
-51% -$13.6M
ABCB icon
73
Ameris Bancorp
ABCB
$6.21B
$13.4M 0.56%
+314,360
New +$13.4M
TECX
74
Tectonic Therapeutic
TECX
$615M
$13.2M 0.56%
54,692
-146
-0.3% -$28.1K
BDSI
75
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$13.2M 0.56%
2,083,126
-1,559
-0.1% -$9.16K
1 2
3
4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Emerald Advisers held 359 positions worth $2.37B, up 11% from $2.14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2019 filing shows 114 new, 58 increased, 128 reduced and 21 closed positions. Its largest new stake was BellRing Brands: 1,634,376 shares worth $34.8M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $33M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Emerald Advisers's largest Q4 2019 buy was BellRing Brands: 1,634,376 shares worth $34.8M.
  • Emerald Advisers added most to Perficient Inc in Q4 2019, an estimated $15.7M increase.
  • Emerald Advisers's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $33M.
  • Emerald Advisers fully exited Arena Pharmaceuticals Inc in Q4 2019, selling an estimated $13.2M.
  • Emerald Advisers's ten largest holdings make up 20% of its $2.37B portfolio in Q4 2019.
  • Emerald Advisers opened 114 new positions and closed 21 in Q4 2019.
  • Emerald Advisers's portfolio value rose 11% quarter-over-quarter to $2.37B.

Based on Emerald Advisers's 13F filing for Q4 2019, filed 29 Jan 2020.